Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("COLESTIPOL")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 166

  • Page / 7

Export

Selection :

  • and

EFFECT OF COLESTIPOL (U-26, 597 A) ON EXPERIMENTAL ATHEROSCLEROSIS IN RABBITSKRITCHEVSKY D; KIM HK; TEPPER SA et al.1973; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1973; VOL. 142; NO 1; PP. 185-188; BIBL. 20 REF.Serial Issue

Colestipol-induced hepatotoxicitySIRMANS, Susan M; BECK, Joni K; HOAN LINH BANH et al.Pharmacotherapy. 2001, Vol 21, Num 4, pp 513-516, issn 0277-0008Article

IN VITRO BINDING OF DRUGS TO COLESTIPOL HYDROCHLORIDE = LA FIXATION IN VITRO DES MEDICAMENTS AU CHLORHYDRATE DE COLESTIPOLKO H; ROYER ME.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 12; PP. 1914-1920; BIBL. 20REF.Article

ERVARINGEN MET EEN NIEUW CHOLESTEROLEMIEVERLAGEND HARS COLESTIPOL, (U-26.597 A UPJOHN). = RESULTATS D'UNE NOUVELLE RESINE CHOLESTEROLEMIANTE, DE COLESTIPOL (U-26597 A, UJJOHN)MULS E; LEMMENS P.1975; ACTA CLIN. BELG.; BELG.; DA. 1975; VOL. 30; NO 5; PP. 409-414; ABS. ANGL. FR.; BIBL. 20 REF.Article

The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatmentKORHONEN, T; HANNUKSELA, M. L; SEPPÄNEN, S et al.European journal of clinical pharmacology. 1999, Vol 54, Num 12, pp 903-910, issn 0031-6970Article

COLESTIPOL AND CHOLESTYRAMINE RESIN. COMPARATIVE EFFECTS IN FAMILIAL TYPE II HYPERLIPOPROTEINEMIA = COLESTIPOL ET LA RESINE DE CHOLESTYRAMINE. EFFETS COMPARATIFS DANS LES HYPERLIPOPROTEINEMIES FAMILIALES DE TYPEIIGLUECK CJ; FORD S JR; SCHEEL D et al.1972; J. AMER. MED. ASS.; U.S.A.; DA. 1972; VOL. 222; NO 6; PP. 676-681; BIBL. 28REF.Serial Issue

CLOFIBRATE-INDUCED LOW DENSITY LIPOPROTEIN ELEVATION THERAPEUTIC IMPLICATIONS AND TREATMENT BY COLESTIPOL RESINROSE HG; HAFT GK; JULIANO J et al.1976; ATHEROSCLEROSIS; NETHERL.; DA. 1976; VOL. 23; NO 3; PP. 413-427; BIBL. 1 P. 1/2Article

LONG-TERM TREATMENT OF HYPERCHOLESTEROLEMIA WITH COLESTIPOL HYDROCHLORIDE = TRAITEMENT A LONG TERME DE L'HYPERCHOLESTEROLEMIE PAR LE CHLORHYDRATE DE COLESTIPOLRYAN JR; JAIN AK; MCMAHON FG et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 1; PP. 83-87; BIBL. 10REF.Article

TERAPIA DELLE IPERLIPOPROTEINEMIE = THERAPEUTIQUE DES HYPERLIPOPROTEINEMIESCREPALDI G; FELLIN R; BRIANI G et al.1974; G. ITAL. CARDIOL.; ITAL.; DA. 1974; VOL. 4; NO 3; PP. 332-340; ABS. ANGL.; BIBL. 27 REF.Article

Use of niacin, statins, and resins in patients with combined hyperlipidemiaBROWN, B. G; ZAMBON, A; POULIN, D et al.The American journal of cardiology. 1998, Vol 81, Num 4A, pp 52B-59B, issn 0002-9149Conference Paper

COLESTIPOL HYDROCHLORIDE, A NEW HYPOLIPIDEMIC DRUG: A TWO-YEAR STUDY = HYDROCHLORURE DE COLESTIPOL: UN NOUVEAU HYPOLIPEMIANT. ETUDE SUR DEUX ANSCOOPER EE; MICHEL AM.1975; SOUTH. MED. J.; U.S.A.; DA. 1975; VOL. 68; NO 3; PP. 303-309; BIBL. 15REF.Article

COLESTIPOL THERAPY OF HYPERLIPIDEMIA IN MAN = TRAITEMENT PAR LE COLESTIPOL DE L'HYPERLIPIDEMIE CHEZ L'HOMMESACHS BA; WOLFMAN L.1974; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1974; VOL. 147; NO 3; PP. 694-697; BIBL. 16REF.Article

NEW MICROPOROUS CHOLESTYRAMINE ANALOG FOR TREATMENT OF HYPERCHOLESTEROLEMIADE SIMONE R; CONTI F; LOVATO MR et al.1978; J. PHARM. SCI.; USA; DA. 1978; VOL. 67; NO 12; PP. 1695-1698; BIBL. 16 REF.Article

EFFECTS OF COLESTIPOL HYDROCHLORIDE ON DRUG ABSORPTION IN THE RAT. I. ASPIRIN, L-THYROXINE, PHENOBARBITAL, CORTISONE AND SULFADIAZINE = EFFETS DU CHLORHYDRATE DE COLESTIPOL SUR L'ABSORPTION DES MEDICAMENTS CHEZ LE RAT. I. ASPIRINE, L-THYROXINE, PHENOBARBITAL, CORTISONE ET SULFADIAZINEPHILLIPS WA; SCHULTZ JR; STAFFORD WW et al.1974; J. PHARM. SCI.; U.S.A.; DA. 1974; VOL. 63; NO 7; PP. 1097-1103; BIBL. 16REF.Article

TRATTEMENTO A LUNGO TERMINE DELL'IPERCOLESTEROLEMIA FAMILIARE CON COLESTIPOL, UNA NUOVA RESINA A SCAMBIO ANIONICO. = TRAITEMENT A LONG TERME DE L'HYPERCHOLESTEROLEMIE FAMILIALE AU MOYEN DU COLESTIPOL, NOUVELLE RESINE ECHANGEUSE D'ANIONSBRIANI G; FELLIN R; BALESTRIERI P et al.1975; G. ITAL. CARDIOL.; ITAL.; DA. 1975; VOL. 5; NO 3; PP. 390-404; ABS. ANGL.; BIBL. 23 REF.Article

In vitro binding of bile salt to rhubarb stalk powderGOEL, V; CHEEMA, S. K; AGELLON, L. B et al.Nutrition research (New York, NY). 1998, Vol 18, Num 5, pp 893-903, issn 0271-5317Article

Effectiveness and Tolerability of Colesevelam Hydrochloride for Bile-Acid Malabsorption in Patients With Cancer: A Retrospective Chart Review and Patient QuestionnaireWEDLAKE, Linda; THOMAS, Karen; LALJI, Amyn et al.Clinical therapeutics. 2009, Vol 31, Num 11, pp 2549-2558, issn 0149-2918, 10 p.Article

ENHANCEMENT OF CHOLESTEROL TURNOVER IN RATS BY A CATATOXIC STEROID (PCN) AND A BILE ACID SEQUESTRANT (COLESTIPOL-HCL) = ACCROISSEMENT DU RENOUVELLEMENT DU CHOLESTEROL CHEZ LES RATS PAR UN STEROIDE CATATOXIQUE (PCN) ET PAR UN SEQUESTRANT DES ACIDES BILIAIRES (LE CHLORHYDRATE DE COLESTIPOL)HONOHAN T; PARKINSON TM.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 8; PP. 899-903; BIBL. 35REF.Article

COLESTIPOL AND CLOFIBRATE IN HYPERCHOLESTEROLEMIA = LE COLESTIPOL ET LE CLOFIBRATE DANS L'HYPERCHOLESTEROLEMIEDUJOVNE CA; HURWITZ A; KAUFFMAN RE et al.1974; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1974; VOL. 16; NO 2; PP. 291-296; BIBL. 17REF.Article

EFFECTS OF COLESTIPOL HYDROCHLORIDE (U-26, 597A) ON SERUM AND FECAL LIPIDS IN DOGS = EFFETS DU CHLORHYDRATE DE COLESTIPOL (U-26597A) SUR LES LIPIDES SERIQUES ET FECAUX CHEZ LES CHIENSPARKINSON TM; SCHNEIDER JC; PHILLIPS WA et al.1973; ATHEROSCLEROSIS; NETHERL.; DA. 1973; VOL. 17; NO 2; PP. 167-179; BIBL. 1P.Serial Issue

Effect of concomitant colestipol hydrochloride administration on the bioavailability of diltiazem from immediate- and sustained-release formulationsTURNER, Scott W; JUNGBLUTH, Gail L; KNUTH, Dean W et al.Biopharmaceutics & drug disposition. 2002, Vol 23, Num 9, pp 369-377, issn 0142-2782, 9 p.Article

A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemiaMCCRINDLE, Brian W; HELDEN, Elizabeth; CULLEN-DEAN, Geraldine et al.Pediatric research. 2002, Vol 51, Num 6, pp 715-721, issn 0031-3998Article

TREATMENT OF RECURRENT ANTIBIOTIC-ASSOCIATED PSEUDOMEMBRANOUS CALITISTEDESCO FJ.1982; AM. J. GASTROENTEROL.; ISSN 0002-9270; USA; DA. 1982; VOL. 77; NO 4; PP. 220-221; BIBL. 12 REF.Article

NORMALIZATION OF LOW-DENSITY-LIPOPROTEIN LEVELS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH A COMBINED DRUG REGIMENKANE JP; MALLOY MJ; TUN P et al.1981; N. ENGL. J. MED.; ISSN 0028-4793; USA; DA. 1981; VOL. 304; NO 5; PP. 251-258; BIBL. 47 REF.Article

FAT-SOLUBLE VITAMIN CONCENTRATIONS IN HYPERCHOLESTEROLEMIC CHILDREN TREATED WITH COLESTIPOLSCHWARZ KB; GOLDSTEIN PD; WITZTUM JL et al.1980; PEDIATRICS; USA; DA. 1980; VOL. 65; NO 2; PP. 243-250; BIBL. 48 REF.Article

  • Page / 7